0
ARTICLE |

Leads From the MMWR FREE

JAMA. 1987;258(6):751-757. doi:10.1001/jama.1987.03400060027009
Text Size: A A A
Published online

REFERENCES

Allen JR, Barsotti DA, Van Miller JP, Abrahamson LJ, Lalich JJ.  Morphological changes in monkeys consuming a diet containing low-levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin . Food Cosmet Toxicol 1977;;15:401-10.
Norback DH, Allen JR.  Biological responses of the nonhuman primate, chicken and rat to chlorinate dibenzo-p-dioxin ingestion . Environ Health Perspect 1973;;5:233-40.
Schwetz BA, Norris JM, Sparschu GL, et al.  Toxicity of chlorinated dibenzo-p-dioxins . Environ Health Perspect 1973;;5:87-99.
Zinkl JG, Vos JG, Moore JA, Gupta BN.  Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals . Environ Health Perspect 1973;; 5:111-8.
CDC. Protocol for epidemiologic studies of the health of Vietnam veterans . Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1983;.
Patterson DG Jr, Hoffman RE, Needham LL, et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin levels in adipose tissue of exposed and control persons in Missouri: an interim report . JAMA 1986;;256:2683-6.
Patterson DG Jr, Needham LL, Pirkle JL, et al.  Levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in paired human serum and adipose tissue samples . Presented at Dioxin 86, Fukuoka, Japan, September 16-19, 1986 .
Crosby DG, Wong AS.  Environmental degradation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) . Science 1977;;195:1337-8.
Nash RG, Beall ML Jr.  Distribution of silvex, 2,4-D, and TCDD applied to turf in chambers and field plots . J Agric Food Chem 1980;;28:614-23.
Jensen DJ, Getzendaner ME, Hummel RA, Turley J.  Residue studies for (2,4,5 trichlorophenoxy) acetic acid and 2,3,7,8-tetrachlorodibenzo-pdioxin in grass and rice . J Agric Food Chem 1983;;31:118-22.
Gross ML, Lay JO Jr, Lyon PA, et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin levels in adipose tissue of Vietnam veterans . Environ Res 1984;;33:261-8.
Kahn PC, Gochfeld M, Rappe C, et al.  Analysis of adipose tissue and blood samples from Vietnam veterans: project outline and preliminary results . Presented at Dioxin 86, Fukuoka, Japan, September 16-19, 1986 .
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or "dioxin".
2,4-dichlorophenoxyacetic acid (2,4-D).
(2,4,5-trichlorophenoxyacetic acid (2,4,5-T).
Ten men who were given scores of less than 5 at the time that invitations were issued were later assigned scores of 5 or more on the basis of corrected company location and military service data provided by ESG.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1981 . MMWR 1982;;31:477-81.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1985 . MMWR 1986;;35:275-6,281-4,315.
Preblud SR, Stetler HC, Frank JA Jr, Greaves WL, Hinman AR, Herrmann KL.  Fetal risk associated with rubella vaccine . JAMA 1981;;246:1413-7.
Bart SW, Stetler HC, Preblud SR, et al.  Fetal risk associated with rubella vaccine: an update . Rev Infect Dis 1985;;7( (suppl 1) ):S95-102.
Banatvala JE, O'Shea S, Best JM, Nicholls MWN, Cooper K.  Transmission of RA27/3 rubella vaccine strain to products of conception (Letter) . Lancet 1981;;1:392.
Furukawa T, Miyata T, Kondo K, Kuno K, Isomura S, Takekoshi T.  Clinical trials of RA 27/3 (Wistar) rubella vaccine in Japan . Am J Dis Child 1969;;118:262-3.
Bernstein DI, Ogra PL.  Fetomaternal aspects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy . J Pediatr 1980;;97:467-70.
O'Shea S, Parsons G, Best JM, Banatvala JE, Balfour HH Jr.  How well do low levels of rubella antibody protect? (Letter) . Lancet 1981;;2:1284.
Balfour HH Jr, Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE.  Rubella viraemia and antibody responses after rubella vaccination and reimmunization . Lancet 1981;;1:1078-80.
CDC. Congenital malformations surveillance report, January 1981-December 1983 . Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1985;.
Sheppard S, Smithells RW, Dickson A, Holzel H.  Rubella vaccination and pregnancy: preliminary report of a national survey . Br Med J 1986;;292:727.
Enders G.  Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy . Rev Infect Dis 1985;; 7( (suppl 1) ):S103-7.
Desmond MM, Montgomery JR, Melnick JL, Cochran GG, Verniaud W.  Congenital rubella encephalitis: effects on growth and early development . Am J Dis Child 1969;;118:30-1.
Ziring PR.  Congenital rubella: the teenage years . Pediatr Ann 1977;;6:762-70.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1982 . MMWR 1983;;32:429-32,437.
ACIP.  Rubella prevention . MMWR 1984;;33: 301-10,315-8.
Use of trade names is for identification only and does not constitute endorsement by the Public Health Service, U.S. Department of Health and Human Services.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Allen JR, Barsotti DA, Van Miller JP, Abrahamson LJ, Lalich JJ.  Morphological changes in monkeys consuming a diet containing low-levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin . Food Cosmet Toxicol 1977;;15:401-10.
Norback DH, Allen JR.  Biological responses of the nonhuman primate, chicken and rat to chlorinate dibenzo-p-dioxin ingestion . Environ Health Perspect 1973;;5:233-40.
Schwetz BA, Norris JM, Sparschu GL, et al.  Toxicity of chlorinated dibenzo-p-dioxins . Environ Health Perspect 1973;;5:87-99.
Zinkl JG, Vos JG, Moore JA, Gupta BN.  Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals . Environ Health Perspect 1973;; 5:111-8.
CDC. Protocol for epidemiologic studies of the health of Vietnam veterans . Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1983;.
Patterson DG Jr, Hoffman RE, Needham LL, et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin levels in adipose tissue of exposed and control persons in Missouri: an interim report . JAMA 1986;;256:2683-6.
Patterson DG Jr, Needham LL, Pirkle JL, et al.  Levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in paired human serum and adipose tissue samples . Presented at Dioxin 86, Fukuoka, Japan, September 16-19, 1986 .
Crosby DG, Wong AS.  Environmental degradation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) . Science 1977;;195:1337-8.
Nash RG, Beall ML Jr.  Distribution of silvex, 2,4-D, and TCDD applied to turf in chambers and field plots . J Agric Food Chem 1980;;28:614-23.
Jensen DJ, Getzendaner ME, Hummel RA, Turley J.  Residue studies for (2,4,5 trichlorophenoxy) acetic acid and 2,3,7,8-tetrachlorodibenzo-pdioxin in grass and rice . J Agric Food Chem 1983;;31:118-22.
Gross ML, Lay JO Jr, Lyon PA, et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin levels in adipose tissue of Vietnam veterans . Environ Res 1984;;33:261-8.
Kahn PC, Gochfeld M, Rappe C, et al.  Analysis of adipose tissue and blood samples from Vietnam veterans: project outline and preliminary results . Presented at Dioxin 86, Fukuoka, Japan, September 16-19, 1986 .
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or "dioxin".
2,4-dichlorophenoxyacetic acid (2,4-D).
(2,4,5-trichlorophenoxyacetic acid (2,4,5-T).
Ten men who were given scores of less than 5 at the time that invitations were issued were later assigned scores of 5 or more on the basis of corrected company location and military service data provided by ESG.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1981 . MMWR 1982;;31:477-81.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1985 . MMWR 1986;;35:275-6,281-4,315.
Preblud SR, Stetler HC, Frank JA Jr, Greaves WL, Hinman AR, Herrmann KL.  Fetal risk associated with rubella vaccine . JAMA 1981;;246:1413-7.
Bart SW, Stetler HC, Preblud SR, et al.  Fetal risk associated with rubella vaccine: an update . Rev Infect Dis 1985;;7( (suppl 1) ):S95-102.
Banatvala JE, O'Shea S, Best JM, Nicholls MWN, Cooper K.  Transmission of RA27/3 rubella vaccine strain to products of conception (Letter) . Lancet 1981;;1:392.
Furukawa T, Miyata T, Kondo K, Kuno K, Isomura S, Takekoshi T.  Clinical trials of RA 27/3 (Wistar) rubella vaccine in Japan . Am J Dis Child 1969;;118:262-3.
Bernstein DI, Ogra PL.  Fetomaternal aspects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy . J Pediatr 1980;;97:467-70.
O'Shea S, Parsons G, Best JM, Banatvala JE, Balfour HH Jr.  How well do low levels of rubella antibody protect? (Letter) . Lancet 1981;;2:1284.
Balfour HH Jr, Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE.  Rubella viraemia and antibody responses after rubella vaccination and reimmunization . Lancet 1981;;1:1078-80.
CDC. Congenital malformations surveillance report, January 1981-December 1983 . Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1985;.
Sheppard S, Smithells RW, Dickson A, Holzel H.  Rubella vaccination and pregnancy: preliminary report of a national survey . Br Med J 1986;;292:727.
Enders G.  Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy . Rev Infect Dis 1985;; 7( (suppl 1) ):S103-7.
Desmond MM, Montgomery JR, Melnick JL, Cochran GG, Verniaud W.  Congenital rubella encephalitis: effects on growth and early development . Am J Dis Child 1969;;118:30-1.
Ziring PR.  Congenital rubella: the teenage years . Pediatr Ann 1977;;6:762-70.
CDC.  Rubella vaccination during pregnancy— United States, 1971-1982 . MMWR 1983;;32:429-32,437.
ACIP.  Rubella prevention . MMWR 1984;;33: 301-10,315-8.
Use of trade names is for identification only and does not constitute endorsement by the Public Health Service, U.S. Department of Health and Human Services.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.